Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A novel stop mutation in the EDNRB gene in a family with Hirschsprung's disease associated with Multiple Sclerosis.
Multiple sclerosis and pregnancy prescriptions.
MRI lesions: a surrogate for relapses in multiple sclerosis?
Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis.
Overview of magnetic resonance imaging for management of relapsing-remitting multiple sclerosis in everyday practice.
Multiple sclerosis and cancer: When two wrongs make a right?
Two functional promoter polymorphisms of neuregulin 1 gene are associated with progressive forms of multiple sclerosis.
Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis.
Teva to present further results of twenty-year open-label extension study of glatiramer acetate 20 mg daily for relapsing-remitting multiple sclerosis
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med
Partial suppression of M1 microglia by Janus kinase 2 inhibitor does not protect against neurodegeneration in animal models of amyotrophic lateral sclerosis.
IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.
The Canadian survey of health, lifestyle and ageing with multiple sclerosis: methodology and initial results.
Caregiver burden in multiple sclerosis: A structured review of the instruments.
The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis.
Evaluation and Treatment of Autoimmune Neurologic Disorders in the Pediatric Intensive Care Unit.
Clinical and Radiological Characterization of Progressive Multifocal Leukoencephalopathy in HIV-Infected Patients: A Retrospective Analysis and Review of the Literature.
Targeting FcRn for therapy: From live cell imaging to in vivo studies in mice.
The Effect of Plasma Exchange on the Expression of FOXP3 and RORC2 in Relapsed Multiple Sclerosis Patients.
Regional brain atrophy and functional connectivity changes related to fatigue in multiple sclerosis.
Changes of statistical structural fluctuations unveils an early compacted degraded stage of PNS myelin.
Application of three focused cluster detection methods to study geographic variation in the incidence of multiple sclerosis in manitoba, Canada.
Regulatory effect of triiodothyronine on brain myelination and astrogliosis after cuprizone-induced demyelination in mice.
Multiple sclerosis: A clinically useful genetic variant in multiple sclerosis?
Cortical thickness at the time of the initial attack in two patients with paediatric relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
564
565
566
567
568
569
570
571
572
…
next ›
last »